National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
RPI.4610

 A substance that is being studied in the treatment of kidney cancer. It may prevent the growth of blood vessels from surrounding tissue to the tumor. It belongs to the families of drugs called VEGF receptor and angiogenesis inhibitors. Also called Angiozyme.

Previous Definitions:romiplostim, ropivacaine, ropivacaine hydrochloride, rosiglitazone, rosiglitazone maleate
Next Definitions:RPR 109881A, RSR13, RSV, RTA 744, RU 486